Immunology of multiple sclerosis

被引：26

作者：

Bar-Or, A

机构：

[1] McGill Univ, Montreal Neurol Inst, Neuroimmunol Unit, Montreal, PQ H3A 2B4, Canada

[2] McGill Univ, Montreal, PQ, Canada

[3] McGill Univ Hosp Ctr, Montreal Neurol Hosp, Montreal, PQ, Canada

来源：

NEUROLOGIC CLINICS | 2005年 / 23卷 / 01期

基金：

加拿大健康研究院;

关键词：

D O I：

10.1016/j.ncl.2004.11.001

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A model of multiple sclerosis (MS) immunopathophysiology is presented to illustrate the basic principles by which peripheral immune responses interact with the blood-brain barrier and have an impact on the central nervous system compartment. The model also considers the putative targets and modes of action of several MS therapies. Overall, this article should provide useful background for more detailed discussions of therapeutic strategies.

引用

收藏

页码：149 / +

页数：28

相关论文

共 185 条

[41] Specialization in tolerance:: Innate CD4+CD25+ versus acquired TR1 and TH3 regulatory T cells [J].

Cottrez, F ;

Groux, H .

TRANSPLANTATION, 2004, 77 (01) :S12-S15

[42] High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay [J].

Crawford, MP ;

Yan, SX ;

Ortega, SB ;

Mehta, RS ;

Hewitt, RE ;

Price, DA ;

Stastny, P ;

Douek, DC ;

Koup, RA ;

Racke, MK ;

Karandikar, NJ .

BLOOD, 2004, 103 (11) :4222-4231

[43] DRAINAGE OF BRAIN EXTRACELLULAR FLUID INTO BLOOD AND DEEP CERVICAL LYMPH AND ITS IMMUNOLOGICAL SIGNIFICANCE [J].

CSERR, HF ;

HARLINGBERG, CJ ;

KNOPF, PM .

BRAIN PATHOLOGY, 1992, 2 (04) :269-276

[44] The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution [J].

Cuzner, ML ;

Gveric, D ;

Strand, C ;

Loughlin, AJ ;

Paemen, L ;

Opdenakker, G ;

Newcombe, J .

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (12) :1194-1204

[45] PROTEOLYTIC-ENZYME ACTIVITY OF BLOOD LEUKOCYTES AND CEREBROSPINAL-FLUID IN MULTIPLE-SCLEROSIS [J].

CUZNER, ML ;

DAVISON, AN ;

RUDGE, P .

ANNALS OF NEUROLOGY, 1978, 4 (04) :337-344

[46]

DAMLE NK, 1993, J IMMUNOL, V151, P2368

[47] Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability [J].

De Stefano, N ;

Narayanan, S ;

Francis, GS ;

Arnaoutelis, R ;

Tartaglia, MC ;

Antel, JP ;

Matthews, PM ;

Arnold, DL .

ARCHIVES OF NEUROLOGY, 2001, 58 (01) :65-70

[48] Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs [J].

de Vos, AF ;

van Meurs, M ;

Brok, HP ;

Boven, LA ;

Hintzen, RQ ;

van der Valk, P ;

Ravid, R ;

Rensing, S ;

Boon, L ;

't Hart, BA ;

Laman, JD .

JOURNAL OF IMMUNOLOGY, 2002, 169 (10) :5415-5423

[49] Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions [J].

deRosbo, NK ;

Hoffman, M ;

Mendel, I ;

Yust, I ;

Kaye, J ;

Bakimer, R ;

Flechter, S ;

Abramsky, O ;

Milo, R ;

Karni, A ;

BenNun, A .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (11) :3059-3069

[50] ICOS co-stimulatory receptor is essential for T-cell activation and function [J].

Dong, C ;

Juedes, AE ;

Temann, UA ;

Shresta, S ;

Allison, JP ;

Ruddle, NH ;

Flavell, RA .

NATURE, 2001, 409 (6816) :97-101

← 1 2 3 4 5 6 7 8 9 10 →